Interferon induced with helicase C domain 1 (IFIH1) and virus-induced autoimmunity: A review

Viral Immunology

Volumn 23, Issue 1, 2010, Pages 3-15

  Chistiakov, Dimitry A ^a  

^a STATE RESEARCH INSTITUTE OF GENETICS AND SELECTION OF INDUSTRIAL MICROORGANISMS   (Russian Federation)

Author keywords

[No Author keywords available]

Indexed keywords

HELICASE; RNA;

ALLELE; AUTOIMMUNE DISEASE; AUTOIMMUNITY; DISEASE PREDISPOSITION; GENE; GENETIC ANALYSIS; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; INTERFERON INDUCED WITH HELICASE C DOMAIN 1 GENE; NONHUMAN; REVIEW; VIRUS;

AUTOIMMUNE DISEASES; DEAD-BOX RNA HELICASES; DISEASE SUSCEPTIBILITY; HUMANS; IMMUNITY, INNATE; INTERFERONS; POLYMORPHISM, GENETIC; VIRUS DISEASES;

EID: 76449083752     PISSN: 08828245     EISSN: None     Source Type: Journal    
DOI: 10.1089/vim.2009.0071     Document Type: Review

References (116)

1. Akanoshi M, Nakashima H, Sadanaga A, et al.: Promoter polymorphisms in the IRF3 gene confer protection against systemic lupus erythematosus. Lupus 2008;17:568-574.
2. Akira S: TLR signaling. Curr Top Microbiol Immunol 2006;31:1-16.
3. Aminkeng F, Van Autreve JE, Weets I, et al.: The association between the IFIH1 locus and type 1 diabetes analysis and genotype-phenotype correlation in the Belgian population. Hum Immunol 2009;70:706-710.
4. Anderton S, Burkhart C, Metzler B, and Wraith D: Mechanisms of central and peripheral T-cell tolerance: lessons from experimental models of multiple sclerosis. Immunol Rev 1999;169:123-137.
5. Asahina Y, Izumi N, Hirayama I, et al.: Potential relevance of cytoplasmic viral sensors and related regulators involving innate immunity in antiviral response. Gastroenterology 2008;134:1396-1405.
6. Bamming D and Horvath CM: Regulation of signal transduction by enzymatically inactive antiviral RNA helicase proteins MDA5, RIG-I, and LGP2. J Biol Chem 2009;284: 9700-9712.
7. Barral PM, Morrison JM, Drahos J, et al.: MDA-5 is cleaved in poliovirus-infected cells. J Virol 2007;81:3677-3684.
8. Barral PM, Sarkar D, Fisher PB, and Racaniello VR: RIG-I is cleaved during picornavirus infection. Virology 2009;391: 171-176.
9. Barral PM, Sarkar D, Su ZZ, et al.: Functions of the cytoplasmic RNA sencors RIG-I and MDA-5: key regulators of innate immunity. Pharmacol Ther (in press) doi: 10.1016/j.pharmathera.2009.06.012/
10. Båve U, Nordmark G, Lövgren T, et al.: Activation of the type I interferon system in primary Sjö gren's syndrome: a possible etiopathogenic mechanism. Arthritis Rheum 2005; 52:1185-1195.
11. Boyhan A, Casimir CM, French JK, Teahan CG, and Segal AW: Molecular cloning and characterization of grancalcin, a novel EF-hand calcium-binding protein abundant in neutrophils and monocytes. J Biol Chem 1992;267:2928-2933.
12. Chehadeh W, Weill J, Vantyghem MC, et al.: Increased level of interferon-alpha in blood of patients with insulindependent diabetes mellitus: relationship with coxsackievirus B infection. J Infect Dis 2000;181:1929-1939.
13. Childs KS, Andrejeva J, Randall RE, and Goodbourn S: Mechanism of mda-5 inhibition by paramyxovirus V proteins. J Virol 2008;83:1465-1473.
14. Chiu CY, Greninger AL, Kanada K, et al.: Identification of cardioviruses related to Theiler's murine encephalomyelitis virus in human infections. Proc Natl Acad Sci USA 2008; 105:14124-14129.
15. Colmegna I and Alberts-Grill N: Parvovirus B19: its role in chronic arthritis. Rheum Dis Clin North Am 2009;35:95-110.
16. Concannon P, Onengut-Gumuscu S, Todd JA, et al.: A human type 1 diabetes susceptibility locus maps to chromosome 21q22.3. Diabetes 2008;57:2858-2861.
17. Couturier N, Gourraud PA, Cournu-Rebeix I, et al.: IFIH1- GCA-KCNH7 locus is not associated with genetic susceptibility to multiple sclerosis in French patients. Eur J Hum Genet 2009;17:844-847.
18. Dessau RB, Nielsen LP, and Frederiksen JL: Absence of entero- and cardioviral RNA in multiple sclerosis brain tissue. Acta Neurol Scand 1997;95:284-286.
19. Devendra D and Eisenbarth GS: Interferon alpha-a potential link in the pathogenesis of viral-induced type 1 diabetes and autoimmunity. Clin Immunol 2004;111:225-233.
20. Devendra D, Jasinski J, Melanitou E, et al.: Interferon-alpha as a mediator of polyinosinic:polycytidylic acid-induced type 1 diabetes. Diabetes 2005;54:2549-2556.
21. Dotta F, Censini S, van Halteren AG, et al.: Coxsackie B4 virus infection of beta cells and natural killer cell insulitis in recent-onset type 1 diabetic patients. Proc Natl Acad Sci USA 2007;104:5115-5120.
22. Dougherty JP, Samanta H, Floyd-Smith G, Broeze R, Jayaram BM, and Lengyel P: Enzymology of interferon action. The (20-50)(A)n synthetase-RNase L pathway. Tex Rep Biol Med 1981-1982;41:443-451.
23. Drescher KM, Kono K, Bopegamage S, Carson SD, and Tracy S: Coxsackievirus B3 infection and type 1 diabetes development in NOD mice: insulitis determines susceptibility of pancreatic islets to virus infection. Virology 2004; 329:381-394.
24. Enevold C, Oturai AB, Sørensen PC, Ryder LP, Koch- Henriksen N, and Bendtzen K: Multiple sclerosis and polymorphisms of innate pattern recognition receptors TLR1-10, NOD1-2, DDX58, and IFIH1. J Neuroimmunol 2009;212:125-131.
25. Fassnacht M, Lee J, Milazzo C, et al.: Induction of CD4+ and CD8+ T-cell responses to the human stromal antigen, fibroblast activation protein: implication for cancer immunotherapy. Clin Cancer Res 2005;11:5566-5571.
26. Fitzgerald KA, McWhirter SM, Faia KL, et al.: IKKe and TBK1 are essential components of the IRF3 signaling pathway. Nat Immunol 2003;4:491-496.
27. Franssila R and Hedman K: Infection and musculoskeletal conditions: Viral causes of arthritis. Best Pract Res Clin Rheumatol 2006;20:1139-1157.
28. Fredericksen BL, Keller BC, Fornek J, Katze MG, and Gale M Jr: Establishment and maintenance of the innate antiviral response to West Nile Virus involves both RIG-I and MDA5 signaling through IPS-1. J Virol 2008;82:609-616.
29. Fujinami RS, von Herrath MG, Christen U, and Whitton JL: Molecular mimicry, bystander activation, or viral resistance: infections and autoimmune disease Clin Microbiol Rev 2006;19:80-94.
30. Gitlin L, Barchet W, Gilfillan S, et al.: Essential role of mda-5 in type I IFN responses to polyriboinosinic: polyribocytidylic acid and encephalomyocarditis picornavirus. Proc Natl Acad Sci USA 2006;103:8459-8464.
31. Graham KL, O'Donnell JA, Tan Y, et al.: Rotavirus infection of infant and young adult nonobese diabetic mice involves extraintestinal spread and delays diabetes onset. J Virol 2007;81:6446-6458.
32. Graham KL, Sanders N, Tan Y, Allison J, Kay TW, and Coulson BS: Rotavirus infection accelerates type 1 diabetes in mice with established insulitis. J Virol 2008;82:6139-6149.
33. Gröschel S, Piggott KD, Vaglio A, et al.: TLR-mediated induction of negative regulatory ligands on dendritic cells. J Mol Med 2008;86:443-455.
34. Guo B, and Cheng G: Modulation of the interferon antiviral response by the TBK1=IKKi adaptor protein TANK. J Biol Chem 2007;282:11817-11826.
35. Honda K, Yanai H, Negishi H, et al.: IRF-7 is the master regulator of type-I interferon-dependent immune responses. Nature 2005;434:772-777.
36. Hornung V, Ellegast J, Kim S, et al.: 50-Triphosphate RNA is the ligand for RIG-I. Science 2006,314:994-997.
37. Jaidane H and Hober D: Role of coxsackievirus B4 in the pathogenesis of type 1 diabetes. Diabetes Metab 2008;34: 537-548.
38. Kang D, Gopalkrishnan RV, Wu Q, Jankowsky E, Pyle AM, and Fisher PB: Mda-5: an interferon-inducible putative RNA helicase with double-stranded RNA-dependent ATPase activity and melanoma growth-suppressive properties. Proc Natl Acad Sci USA 2002;99:637-642.
39. Kato H, Takeuchi O, Sato S, et al.: Differential roles of MDA5 and RIG-I helicases in the recognition of RNA viruses. Nature 2006;441:101-105.
40. Kato H, Takeuchi O, Mikamo-Satoh E, et al.: Lengthdependent recognition of double-stranded ribonucleic acids by retinoic acid-inducible gene-I and melanoma differentiation- associated gene 5. J Exp Med 2008;205:1601-1610.
41. Kawai T, Takahashi K, Sato S, et al.: IPS-1, an adaptor triggering RIG-I- and Mda5-mediated type I interferon induction. Nat Immunol 2005;6:981-988.
42. Kayagaki N, Phung Q, Chan S, et al.: DUBA: A deubiquitinase that regulates Type I interferon production. Science 2007;318:1628-1632.
43. Kumar H, Kawai T, Kato H, et al.: Essential role of IPS-1 in innate immune responses against RNA viruses. J Exp Med 2006;203:1795-1803.
44. Kuusisto H, Hyö ty H, Kares S, Kinnunen E, Saarelainen M, and Elovaara I: Enteroviruses and the risk of MS in the Finnish Twin Cohort. Eur J Neurol 2005;12:707-709.
45. Li Q, Xu B, Michie SA, Rubins KH, Schreriver RD, and McDevitt HO: Interferon-alpha initiates type 1 diabetes in nonobese diabetic mice. Proc Natl Acad Sci USA 2008;105: 12439-12444.
46. Li X, Ranjith-Kumar CT, Brooks MT, et al.: The RIG-I-like receptor LGP2 recognizes the termini of double-stranded RNA. J Biol Chem 2009;284:13881-13891.
47. Liu S, Wang H, Jin Y, et al.: IFIH1 polymorphisms are significantly associated with type 1 diabetes and IFIH1 gene expression in peripheral blood mononuclear cells. Hum Mol Genet 2009;18:358-365.
48. Longhi MP, Trumpfheller C, Idovaga J, et al.: Dendritic cells require a systemic type I interferon response to mature and induce CD4+ Th1 immunity with poly IC as adjuvant. J Exp Med 2009;206:1589-1602.
49. Loo YM, Fornek J, Crochet N, et al.: Distinct RIG-I and MDA5 signaling by RNA viruses in innate immunity. J Virol 2008;82:335-345.
50. Lunemann JD and Munz C: Epstein-Barr virus and multiple sclerosis. Curr Neurol Neurosci Rep 2007;7:253-258.
51. Marinou I, Montgomery DS, Dickson MC, et al.: The interferon induced with helicase domain 1 A946T polymorphism is not associated with rheumatoid arthritis. Arthritis Res Ther 2007;9:R40.
52. Martínez A, Santiago L, Cénit C, et al.: IFIH1-GCA-KCNH7 locus: influence on multiple sclerosis risk. Eur J Hum Genet 2008;16:861-864.
53. Martínez A, Varadé J, Lamas JR, et al.: Association of the IFIH1-GCAKCNH7 chromosomal region with rheumatoid arthritis. Ann Rheum Dis 2008;67:137-138.
54. McAllister CS and Samuel CE: The RNA-activated protein kinase enhances the induction of interferon-beta and apoptosis mediated by cytoplasmic RNA sensors. J Biol Chem 2009;284:1644-1651.
55. Metsküla K, Salur L, Mandel M, and Uibo R: Demonstration of high prevalence of SS-A antibodies in a general population: association with HLA-DR and enterovirus antibodies. Immunol Lett 2006;106:14-18.
56. Meurs E, Chong K, Galabru J, et al.: Molecular cloning and characterization of the human double-stranded RNAactivated protein kinase induced by interferon. Cell 1990;62: 379-390.
57. Miller SD, Katz-Levy Y, Neville KL, and Vanderlugt CL: Virus-induced autoimmunity: epitope spreading to myelin autoepitopes in Theiler's virus infection of the central nervous system. Adv Virus Res 2001;56:199-217.
58. Moriyama H, Wen L, Abiru N, et al.: Induction and acceleration of insulitis=diabetes in mice with a viral mimic (polyinosinic-polycytidylic acid) and an insulin selfpeptide. Proc Natl Acad Sci USA 2002;99:5539-5544.
59. Müblbauer E, Bazwinsky I, Wolqast S, Klemenz A, and Peschke E: Circadian changes of ether-a-go-go-related-gene (Erg) potassium channel transcripts in the rat pancreas and b-cell. Cell Mol Life Sci 2007;64:768-780.
60. Myong S, Cui S, Cornish PV, et al.: Cytosolic viral sensor RIG-I is a 50triphosphate-dependent translocase on doublestranded RNA. Science 2009;323:1070-1074.
61. Nakhaei P, Genin P, Civas A, and Hiscott J: RIG-I like receptors: sensing and responding to RNA virus infection. Semin Immunol (in press) doi: 10.1016=j.smim.2009.05.001.
62. Nejentsev S, Walker N, Riches D, Egholm M, and Todd JA: Rare variants of IFIH1, a gene implicated in antiviral responses, protect against type 1 diabetes. Science 2009;324: 387-389.
63. Nishino T, Komori K, Tsuchiya D, Ishino Y, and Morikawa K: Crystal structure and functional implications of Pyrococcus furiosus hef helicase domain involved in branched DNA processing. Structure 2005;13:143-153.
64. Oganesyan G, Saha SK, Guo B, et al.: Critical role of TRAF3 in the Toll-like receptor-dependent and independent antiviral response. Nature 2006;439:208-211.
65. Olson JK, Eagar TN, and Miller SD: Functional activation of myelin-specific T cells by virus-induced molecular mimicry. J Immunol 2002;169:2719-2726.
66. Olson JK, Ercolini AM, and Miller SD: A virus-induced molecular mimicry model of multiple sclerosis. Curr Top Microbiol Immunol 2005;296:39-53.
67. Olson JK and Miller SD: The innate immune response affects the development of the autoimmune response in Theiler's virus-induced demyelinating disease. J Immunol 2009;182:5712-5722.
68. Onodera T, Toniolo A, Ray UR, Jenson AB, Knazek RA, and Notkins AL: Virus-induced diabetes mellitus. XX. Polyendocrinopathy and autoimmunity. J Exp Med 1981;153: 1457-1473.
69. Papon L, Oteiza A, Imaizumi T, et al.: The viral RNA recognizition sensor RIG-I is degraded during encephalomyocarditis virus (EMCV) infection. Virology (in press) doi: 10.1016=j.virol.2009.08.009.
70. Parisien JP, Bamming D, Komuro A, et al.: A shared interface mediates paramixovirus interference with antiviral RNA helicases MDA5 and LPG2. J Virol 2009;83:7252-7260.
71. Paronen J, Liu E, Moriyama H, et al.: Genetic differentiation of poly I:C from B:9-23 peptide induced experimental autoimmune diabetes. J Autoimmun 2004;22:307-313.
72. Pathak HB, Oh HS, Goodfellow IG, Arnold JJ, and Cameron CE: Picornavirus genome replication: roles of precursor proteins and rate-limiting steps in oriI-dependent VPg uridylylation. J Biol Chem 2008;283:30677-30688.
73. Pessia M, Servettini I, Panichi R, et al.: ERG voltage-gated K+ channels regulate excitability and discharge dynamics of the medial vestibular nucleus neurones. J Physiol 2008; 586:4877-4890.
74. Potter C, Eyre S, Cope A, Worthington J, and Barton A: Investigation of association between the TRAF family genes and RA susceptibility. Ann Rheum Dis 2007;66:1322-1326.
75. Richardson SJ, Willcox A, Bone AJ, Foulis AK, and Morgan NG: The prevalence of enteroviral capsid protein vp1 immunostaining in pancreatic islets in human type 1 diabetes. Diabetologia 2009;52:1143-1151.
76. Pichlmair A, Schulz O, Tan CP, et al.: RIG-I-mediated antiviral responses to single-stranded RNA bearing 50- phosphates. Science 2006; 314:997-1001.
77. Posnett DN: Herpesviruses and autoimmunity. Curr Opin Investig Drugs 2008;9:505-514.
78. Qu HQ, Marchand L, Grabs R, and Polychronakos C: The association between the IFIH1 locus and type 1 diabetes. Diabetologia 2008;51:473-475.
79. Rieder M and Conzelmann KK: Rhabdovirus evasion of the interferon system. J Interferon Cytokine Res (in press) doi:10.1089=jir.2009.0068.
80. Ryzhakov G and Randow F: SINTBAD, a novel component of innate antiviral immunity, shares a TBK1-binding domain with NAP1 and TANK. EMBO J 2007;26:3180-3190.
81. Saggese G, Federico G, Garzelli C, and Toniolo A: Insulindependent diabetes: a possible viral disease. Pediatrician 1983-1985;12:179-193.
82. Saha SK, Pietras EM, He JQ, et al.: Regulation of antiviral responses by a direct and specific interaction between TRAF3 and Cardif. EMBO J 2006;25:3257-3263.
83. Saito T, Owen DM, Jiang F, Marcotrigiano J, and Gale M Jr: Innate immunity induced by composition-dependent RIG-I recognition of hepatitis C virus RNA. Nature 2008;454:523-527.
84. Samuel CE: Antiviral actions of interferons. Clin Microbiol Rev 2001;14:778-809.
85. Sánchez E, González-Gay MA, Catejas-Rubio JL, et al.: No evidence for genetic association of interferon regulatory factor 3 in systemic lupus erythematosus. Lupus 2009;18: 230-234.
86. Sasai M, Shingai M, Funami K, et al.: NAK-associated protein 1 participates in both the TLR3 and the cytoplasmic pathways in type I IFN induction. J Immunol 2006;177: 8676-8683.
87. Schmidt A, Schwerd T, Hamm W, et al.: 50-Triphosphate RNA requires base-paired structures to activate antiviral signaling via RIG-I. Proc Natl Acad Sci USA 2009;106: 12067-12072.
88. Scott I: Mitochondrial factors in the regulation of innate immunity. Microbes Infect 2009;11:729-736.
89. Selmi C, Lleo A, Zuin M, Podda M, Rossaro L, and Gershwin ME: Interferon alpha and its contribution to autoimmunity. Curr Opin Investig Drugs 2006;7:451-456.
90. Serreze DV, Wasserfall C, Ottendorfer EW, et al.: Diabetes acceleration or prevention by a Coxsackievirus B4 infection: critical requirements for both interleukin-4 and gamma interferon. J Virol 2005;79:1045-1052.
91. Seth RB, Sun L, Ea CK, and Chen ZJ: Identification and characterization of MAVS, a mitochondrial antiviral signaling protein that activates NF-kappaB and IRF 3. Cell 2005;122:669-682.
92. Sherry B: Rotavirusandreovirus modulationof the interferon response. J Interferon Cytokine Res (in press) doi:10.1089= jir.2009.0072.
93. Shigemoto T, Kageyama M, Hirai R, Zheng J, Yoneyama M, and Fujita T: Identification of loss of function mutations in human genes encoding RIG-I and MDA5: implications for resistance to type I diabetes. J Biol Chem 2009;284:13348-13354.
94. Smith AK, Lange LA, Amperfolrd EJ, Meyers DA, Bleecker ER, and Howard TD: Association of polymorphisms in CASP10 and CASP8 with FEV(1)=FVC and bronchial hyperresponsiveness in ethnically diverse asthmatics. Clin Exp Allergy 2008;38:1738-1744.
95. Smyth DJ, Cooper JD, Bailey R, et al.: A genome-wide association study of nonsynonymous SNPs identifies a type 1 diabetes locus in the interferon-induced helicase (IFIH1) region. Nat Genet 2006;38:617-619.
96. Sumpter R Jr, Loo YM, Foy E, et al.: Regulating intracellular antiviral defense and permissiveness to hepatitis C virus RNA replication through a cellular RNA helicase, RIG-I. J Virol 2005;79:2689-2699.
97. Sutherland A, Davies J, Owen CJ, et al.: Genomic polymorphism at the interferon-induced helicase (IFIH1) locus contributes to Graves' disease susceptibility. Clin Endocrinol Metab 2007;92:3338-3341.
98. Tak P: IFN-beta in rheumatoid arthritis. Front Biosci 2004;9:3242-3247.
99. Takahashi K, Kawai T, Kumar H, Sato S, Yonehara S, and Akira S: Roles of caspase-8 and caspase-10 in innate immune responses to double-stranded RNA. J Immunol 2006; 176:4520-4524.
100. Takahasi K, Yoneyama M, Nishihori T, et al.: Nonself RNAsensing mechanism of RIG-I helicase and activation of antiviral immune responses. Mol Cell 2008;29:428-440.
101. Tenoever BR, Ng SL, Chua MA, McWhirter SM, Garcia- Sastre A, and Maniatis T: Multiple functions of the IKK- related kinase IKKepsilon in interferon-mediated antiviral immunity. Science 2007;315:1274-1278.
102. Theofilopoulos AN, Baccala R, Beutler B, and Kono DH: Type I interferons (alpha=beta) in immunity and autoimmunity. Annu Rev Immunol 2005;23:307-336.
103. Thompson AJ and Locarnini SA: Toll-like receptors, RIG-Ilike RNA helicases and the antiviral innate immune response. Immunol Cell Biol 2007;85:435-445.
104. Tozzoli R, Barzilai O, Ram M, et al.: Infections and autoimmune thyroid diseases: parallel detection of antibodies against pathogens with proteomic technology. Autoimmun Rev 2008;8:112-115.
105. Triantafyllopoulou A and Moutsopoulos HM: Autoimmunity and coxsackievirus infection in primary Sjogren's syndrome. Ann NY Acad Sci 2005;1050:389-396.
106. Triantafyllopoulou A, Tapinos N, and Moutsopoulos HM: Evidence for coxsackievirus infection in primary Sjogren's syndrome. Arthritis Rheum 2004;50:2897-2902.
107. van Holten J, Smeets TJ, Blankert P, and Tak PP: Expression of interferon beta in synovial tissue from patients with rheumatoid arthritis: comparison with patients with osteoarthritis and reactive arthritis. Ann Rheum Dis 2005;64: 1780-1782.
108. Vinuesa CG and Cook MC: Genetic analysis of systemic autoimmunity. Novartis Found Symp 2007;281:103-120.
109. Welsh CJ, Steelman AJ, Mi W, et al.: Neuroimmune interactions in a model of multiple sclerosis. Ann NY Acad Sci 2009;1153:209-219.
110. Williams BR: Signal integration via PKR. Sci STKE 2001; 2001(89):RE2.
111. Williams CH, Oikarinen S, Tauriainen S, Salminen K, Hyoty H, and Stanway G: Molecular analysis of an echovirus 3 strain isolated from an individual concurrently with appearance of islet cell and IA-2 autoantibodies. J Clin Microbiol 2006;44:441-448.
112. Ylipaasto P, Klingel K, Lindberg AM, et al.: Enterovirus infection in human pancreatic islet cells, islet tropism in vivo and receptor involvement in cultured islet b cells. Diabetologia 2004;47:225-239.
113. Yoneyama M, Kikuchi M, Matsumoto K, et al.: Shared and unique functions of the DExD=H-box helicases RIG-I, MDA5, and LGP2 in antiviral innate immunity. J Immunol 2005;175:2851-2858.
114. Yoneyama M and Fujita, T.: RNA recognition and signal transduction by RIG-I-like receptors. Immunol Rev 2009; 227:54-65.
115. Zanone MM, Favaro E, Ferioli E, et al.: Human pancreatic islet endothelial cells express coxsackievirus and adenovirus receptor and are activated by coxsackie B virus infection. FASEB J 2007;21:3308-3317. (Pubitemid 47565549)
116. Zhao Z-F, Cui B, Chen HY, et al.: The A946T polymorphism in the interferon induced helicase gene does not confer susceptibility to Graves' disease in Chinese population. Endocrine 2007;32:143-147.